Stockreport

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Allurion Technologies, Inc.  (ALUR) 
PDF Average Total Weight Loss of 20% With 15% Increase in Lean Body Mass After 8 Months of Combined Therapy NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“ [Read more]